Systematic Ambulatory ECG Monitoring Following TAVI

Starting soon · Not applicable

Conditions studied: Aortic Stenosis, Conduction Disturbances

In brief

This multicenter, prospective, randomized superiority trial will evaluate whether systematic 14-day ambulatory ECG monitoring following hospital discharge after transcatheter aortic valve implantation (TAVI) reduces the risk of sudden death, symptomatic arrhythmic events, or stroke within 1 year compared with standard post-discharge care. Patients undergoing successful TAVI without permanent pacemaker implantation and presenting with at least one ECG conduction abnormality at hospital discharge will be randomized to receive either ambulatory ECG monitoring or standard follow-up. All participants will undergo routine clinical follow-up at 30 days and 1 year after TAVI.

Key facts

Study ID

NCT07739316

Run by

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

People needed

754

Starts

2026-08-01

Expected to finish

2028-12-01

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years
• Successful TAVI procedure.
• Hospitalization discharge ≤72 hrs following the TAVI procedure.
• Presence of at least 1 ECG abnormality at hospital discharge (QRS ≥120 ms OR PR ≥200 ms)

You may not qualify if…

• Pacemaker implantation (pre- TAVI or during hospitalization after the procedure).
• TAVI valve-in-valve procedure
• Any complication or logistic reason precluding hospital discharge ≤72 hrs following the TAVI procedure.
• Impossibility to obtain signed informed consent.

Where it is running

• Institut universitaire de cardiologie et de pneumologie de Québec - UL — Québec, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.